Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1976 Sep 30;10(5):297-303.
doi: 10.1007/BF00565617.

Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man

Clinical Trial

Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man

J F De Plaen et al. Eur J Clin Pharmacol. .

Abstract

The comparative potency of two beta-blockers, propranolol and atenolol, in the inhibition of exercise tachycardia and isoproterenol-tachycardia has been studied in two groups of hypertensive patients, using oral doses which were increased weekly. A linear correlation was observed between the reduction in exercise tachycardia and the dose of each drug, up to a daily dose of propranolol 480 mg and atenolol 600 mg. Propranolol was slightly (0.7/1) more potent in decreasing maximal exercise tachycardia than atenolol when tested in low doses (below 100 mg); at higher doses (480 mg) no differences were found. However, atenolol was 10 times less potent than propranolol in blocking isoprenaline-induced tachycardia, which seems to be related to the cardioselectivity of atenolol.

PubMed Disclaimer

References

    1. Int Z Klin Pharmakol Ther Toxikol. 1970 Dec;4(1):125-30 - PubMed
    1. Arch Int Pharmacodyn Ther. 1975 Feb;213(2):294-306 - PubMed
    1. Br J Pharmacol. 1973 Sep;49(1):154P-155P - PubMed
    1. Br Med J. 1975 May 17;2(5967):367-70 - PubMed
    1. Acta Med Scand. 1973 Dec;194(6):549-50 - PubMed

LinkOut - more resources